Last updated on January 2020

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis


Brief description of study

The purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the treatment of subjects with active ankylosing spondylitis (AS).

Clinical Study Identifier: NCT03928743

Find a site near you

Start Over

As0011 50060

Upland, CA United States
  Connect »

As0011 50015

Hagerstown, MD United States
  Connect »

As0010 50016

Saint Louis, MO United States
  Connect »

As0011 50020

Duncansville, PA United States
  Connect »

As0011 50054

Oklahoma City, OK United States
  Connect »

As0011 50001

Jackson, TN United States
  Connect »

As0011 50012

Memphis, TN United States
  Connect »

As0011 40032

Debrecen, Hungary
  Connect »

As0011 40007

Plovdiv, Bulgaria
  Connect »

As0011 40008

Sofia, Bulgaria
  Connect »

As0011 40031

Szeged, Hungary
  Connect »

As0011 50062

Glendale, AZ United States
  Connect »

As0011 50052

Phoenix, AZ United States
  Connect »

As0011 50058

Phoenix, AZ United States
  Connect »

As0011 50131

Sun City, AZ United States
  Connect »

As0011 50056

Sarasota, FL United States
  Connect »

As0011 50016

Saint Louis, MO United States
  Connect »

As0011 50053

Austin, TX United States
  Connect »

As0011 50057

Dallas, TX United States
  Connect »

As0011 50036

Mesquite, TX United States
  Connect »

As0011 50027

Seattle, WA United States
  Connect »

As0011 40004

Brussels, Belgium
  Connect »

As0011 40006

Plovdiv, Bulgaria
  Connect »

As0011 40005

Sofia, Bulgaria
  Connect »

As0011 40009

Pardubice, Czechia
  Connect »

As0011 40013

Praha 11, Czechia
  Connect »

As0011 40016

Praha 2, Czechia
  Connect »

As0011 40015

Praha 3, Czechia
  Connect »

As0011 40014

Praha 4, Czechia
  Connect »

As0011 40010

Uherské Hradišt?, Czechia
  Connect »

As0011 40018

Boulogne-Billancourt, France
  Connect »

As0011 40025

Berlin, Germany
  Connect »

As0011 40028

Berlin, Germany
  Connect »

As0011 40029

Hamburg, Germany
  Connect »

As0011 40024

Hannover, Germany
  Connect »

As0011 40026

Ratingen, Germany
  Connect »

As0011 40080

Szombathely, Hungary
  Connect »

As0011 20039

Iruma-Gun, Japan
  Connect »

As0011 20036

Kawachi-Nagano, Japan
  Connect »

As0011 20031

Sapporo-City, Japan
  Connect »

As0011 40034

Amsterdam, Netherlands
  Connect »

As0011 40042

Kraków, Poland
  Connect »

As0011 40039

Wroc?aw, Poland
  Connect »

As0011 40043

Wroc?aw, Poland
  Connect »

As0011 40048

Santiago De Compostela, Spain
  Connect »

As0011 40050

Istanbul, Turkey
  Connect »

As0011 40057

Edinburgh, United Kingdom
  Connect »

As0011 40055

Norwich, United Kingdom
  Connect »

As0011 40010

Uherské Hradišt?, Czechia
  Connect »

As0011 40033

Székesfehérvár, Hungary
  Connect »

As0011 40042

Kraków, Poland
  Connect »

As0011 40039

Wroc?aw, Poland
  Connect »

As0011 40043

Wroc?aw, Poland
  Connect »

As0011 40010

Uherské Hradišt?, Czechia
  Connect »

As0011 40033

Székesfehérvár, Hungary
  Connect »

As0011 20065

Kitakyushu, Japan
  Connect »

As0011 40035

Rotterdam, Netherlands
  Connect »

As0011 40042

Kraków, Poland
  Connect »

As0011 40039

Wroc?aw, Poland
  Connect »

As0011 40043

Wroc?aw, Poland
  Connect »

As0011 40010

Uherské Hradišt?, Czechia
  Connect »

As0011 40021

Orléans, France
  Connect »

As0011 40033

Székesfehérvár, Hungary
  Connect »

As0011 40042

Kraków, Poland
  Connect »

As0011 40039

Wroc?aw, Poland
  Connect »

As0011 40043

Wroc?aw, Poland
  Connect »

As0011 40046

Córdoba, Spain
  Connect »

As0011 40056

Leeds, United Kingdom
  Connect »

As0011 40010

Uherské Hradišt?, Czechia
  Connect »

As0011 40021

Orléans, France
  Connect »

As0011 40033

Székesfehérvár, Hungary
  Connect »

As0011 40042

Kraków, Poland
  Connect »

As0011 40039

Wroc?aw, Poland
  Connect »

As0011 40043

Wroc?aw, Poland
  Connect »

As0011 40046

Córdoba, Spain
  Connect »